|

Intraperitoneal Paclitaxel Clinical Trials

2 actively recruiting trials across 1 location

Pipeline

Phase 3: 1Phase 2/3: 1

Top Sponsors

  • Magnus Nilsson1
  • ECOG-ACRIN Cancer Research Group1

Indications

  • Cancer2
  • Gastric Cancer Peritoneal Metastases1
  • Gastroesophageal Junction Adenocarcinoma1
  • Gastric Adenocarcinoma1
  • Peritoneal Carcinomatosis1

Other1 trial

Intraperitoneal Paclitaxel and Systemic Therapy Versus Systemic Therapy Alone in Gastric Cancer Patients With Peritoneal Metastasis
Phase 3

Irvine, California1 trial

Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity

UC Irvine Health/Chao Family Comprehensive Cancer Center

Phase 2/3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.